ABA Editorial · Sep 13, 2025 · 13 min read
African telemedicine addresses one of the continent's most binding healthcare constraints: doctor-to-patient ratios that sometimes reach one doctor per 5,000 people. Babyl in Rwanda has delivered millions of digital consultations through a government partnership. Vezeeta operates a multi-country appointment platform with USD 40 million in cumulative funding. This report maps the telemedicine landscape.
Telemedicine addresses one of the most binding constraints in African healthcare: the shortage of qualified physicians relative to population size. Some African countries operate with physician-to-patient ratios as low as one doctor per 5,000 people, compared to ratios closer to one per 300 in high-income countries. The physical distribution of doctors is additionally skewed, with the majority of physicians concentrated in urban centers and relatively few in rural areas where the majority of populations live. Telemedicine offers a specific response: leveraging the limited pool of trained physicians more efficiently by allowing them to consult remotely with patients who could not otherwise access a doctor within a reasonable distance. Several African operators have built telemedicine businesses targeting different segments of this opportunity, from government-partnership mass-scale operations to premium commercial services. This report maps the telemedicine landscape and the operators who have built it.
Babyl, operating in Rwanda, is the highest-volume African telemedicine operator by consultation count. The company delivers digital consultations through a partnership with the Government of Rwanda, which has made digital health a priority area in its broader technology and development strategy. The Babyl model allows Rwandans to access medical consultation via mobile phone, with follow-up referrals to physical facilities when necessary. The company has reported millions of consultations delivered through the platform over successive years of operation.
The Babyl model works because the government partnership solves two specific problems that pure commercial telemedicine operators face. First, it provides customer acquisition at scale through official government channels rather than requiring expensive marketing to individual patients. Second, it provides a revenue model through the government partnership rather than depending on individual patient payments that many users cannot sustain. The tradeoff is that the operator is dependent on the continuing political and fiscal commitment of the host government, which creates its own risks.
Vezeeta, originally founded in Egypt, has built a multi-country appointment booking and telemedicine platform operating across Egypt, Saudi Arabia, Jordan, and several other markets. The company has raised approximately USD 40 million in cumulative funding and has expanded its scope from simple appointment booking to include medical information content, medication information, and direct consultation services. Vezeeta's geographic footprint crosses the boundary between the African continent and the Middle East, reflecting the commercial reality that Egyptian-headquartered health companies often find better commercial opportunities in Gulf markets than in Sub-Saharan African markets.
The Vezeeta experience illustrates a broader pattern in African healthtech: operators founded in African markets often find their most attractive growth opportunities in adjacent non-African markets where commercial infrastructure is more mature. This is not necessarily a failure of the African market; it reflects the realistic commercial choices that operators must make to build sustainable businesses. The question for African healthtech policy is whether the operators eventually redirect their African operations once they have achieved scale in adjacent markets, or whether African operations remain subordinate to growth elsewhere.
Reliance Health in Nigeria has built a telemedicine offering integrated with its health insurance operations. Patients who subscribe to Reliance insurance plans can access telemedicine consultations as part of their coverage, which addresses the payment problem by bundling the consultation cost into the insurance premium rather than requiring separate payment at the point of service. The model has been attractive to Nigerian employer groups purchasing insurance for their employees, because the telemedicine component improves the perceived value of the insurance product at a relatively modest cost addition.
Through 2025, Reliance Health reportedly laid off more than 100 employees as the company sought to reach break-even, reflecting the broader African healthtech correction. The telemedicine component remains operationally central to the company's offering even as the overall business has restructured around sustainability rather than growth.
A smaller set of African telemedicine operators focuses specifically on specialist consultations: dermatology, radiology, psychiatry, oncology, and other specialties where the physician shortage is particularly acute. Specialist consultation is well-suited to telemedicine because the interactions are less dependent on physical examination than primary care, and because the economic value of each consultation is higher, supporting the operational costs of the telemedicine platform. Operators in this niche can operate at smaller scale than mass-market primary care telemedicine while still achieving acceptable unit economics.
Telemedicine cannot replace all categories of healthcare. Physical examinations, surgical interventions, diagnostic procedures, and emergency care all require in-person facilities that no digital platform can substitute for. The realistic role of telemedicine in African health systems is as a complement to physical infrastructure rather than a replacement for it. A patient might receive initial consultation remotely, get a referral to a physical facility when necessary, and then receive follow-up care remotely after the physical intervention. This hybrid model requires both digital platforms and physical infrastructure to function reliably, which means that telemedicine operators depend on the broader health system functioning at a minimum level.
The implication is that telemedicine investment and physical health system investment are complementary rather than competing. African health systems that neglect either component will struggle to deliver comprehensive care, regardless of how sophisticated the telemedicine platforms become.
Three indicators will shape African telemedicine. First, whether Babyl's Rwandan model is replicated through government partnerships in additional African countries, extending the mass-scale access approach to new populations. Second, whether insurance-integrated telemedicine offerings like Reliance Health's continue to scale despite the broader sector correction, validating the bundled payment model. Third, whether specialist consultation telemedicine finds commercially sustainable scale in markets where the physician shortage is most acute. Telemedicine is not a silver bullet for African healthcare constraints, but it is one of the most accessible interventions available in the short term, and its trajectory will shape how quickly the continent can expand effective access to medical consultation.